SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001558370-21-015386
Filing Date
2021-11-10
Accepted
2021-11-10 06:46:14
Documents
14
Period of Report
2021-11-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K hook-20211110x8k.htm   iXBRL 8-K 37656
2 EX-99.1 hook-20211110xex99d1.htm EX-99.1 102900
3 GRAPHIC hook-20211110xex99d1001.jpg GRAPHIC 108613
  Complete submission text file 0001558370-21-015386.txt   425468

Data Files

Seq Description Document Type Size
4 EX-101.SCH hook-20211110.xsd EX-101.SCH 3053
5 EX-101.LAB hook-20211110_lab.xml EX-101.LAB 16739
6 EX-101.PRE hook-20211110_pre.xml EX-101.PRE 10625
7 EXTRACTED XBRL INSTANCE DOCUMENT hook-20211110x8k_htm.xml XML 5085
Mailing Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016
Business Address 430 EAST 29TH STREET 14TH FLOOR NEW YORK NY 10016 0114318906360
HOOKIPA Pharma Inc. (Filer) CIK: 0001760542 (see all company filings)

IRS No.: 815395687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38869 | Film No.: 211394312
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences